Search News
| 354.98 Delayed Data As of Jul 17 |  +1.95 / +0.55%Today’s Change | 249.17 Today|||52-Week Range 370.57 | +11.43% Year-to-Date |
| Previous close | 353.03 |
| Today’s open | 352.20 |
| Day’s range | 351.52 - 356.02 |
| Volume | 1,486,429 |
| Average volume (3 months) | 1,819,822 |
| Market cap | $59.6B |
| Earnings growth (last year) | -29.56% |
| Earnings growth (this year) | +9.42% |
| Earnings growth (next 5 years) | +4.37% |
| Revenue growth (last year) | +7.81% |
| P/E ratio | 25.4 |
| Price/Sales | 6.17 |
| Price/Book | 4.73 |
| Next reporting date | July 24, 2018 |
| EPS forecast (this quarter) | $5.32 |
| Annual revenue (last year) | $11.0B |
| Annual profit (last year) | $2.5B |
| Net profit margin | 23.10% |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Director Michel Vounatsos |
Chief Financial Officer & Executive Vice President Jeffrey D. Capello |
Corporate headquarters Cambridge, Massachusetts |
